Examining the clinical and economic impact of medical innovations is essential to understanding their value to patients and to the health care system as a whole. Health insurers and providers are unlikely to adopt a medical innovation without evidence of its value. A Value Strategy should take a number of different forms depending on the innovation being studied, its clinical impact, the target outcomes, the audience examining the analyses, the availability of data, and choices of analytical tools.

Strategic Health Resources has an impressive history of assisting medical device, diagnostic, biotechnology and pharmaceutical companies in developing successful Medical Innovation Value Strategies. The related links in this website describe our philosophy, analytical approaches and tools and list some of our client references.

For more information, contact Strategic Health Resources® at (818) 952-5130.


[include ^pagecounter.tpl]